サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1732945

人工血管市場- 世界の産業規模、シェア、動向、機会、予測：用途別、ポリマー別、地域別、競合別、2020-2030年

Artificial Blood Vessels Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Application, By Polymer, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 183 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

人工血管市場- 世界の産業規模、シェア、動向、機会、予測：用途別、ポリマー別、地域別、競合別、2020-2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工血管の世界市場は、2024年に3億158万米ドルと評価され、予測期間中にCAGR 5.74％で拡大し、2030年には4億2,151万米ドルに達すると予測されています。

同市場は医療機器産業の重要なセグメントであり、心血管および血管疾患の治療用人工血管の開発と応用に焦点を当てています。人工血管の人工血管は、合成血管と組織工学の両方があり、バイパス手術、血液透析アクセス、大動脈修復などの救命処置に不可欠です。この分野では、材料科学と移植片の設計に顕著な進歩が見られ、安全性、耐久性、手術成績が向上しています。さらに、低侵襲手技へのシフトが、回復時間と手技リスクを軽減する高度な人工血管への需要を加速し、市場を持続的成長へと位置づけています。

市場概要
予測期間 2026-2030
市場規模：2024年 3億158万米ドル
市場規模：2030年 4億2,151万米ドル
CAGR：2025年～2030年 5.74%
急成長セグメント 大動脈疾患
最大市場 北米

市場促進要因

心血管疾患の有病率の上昇

主な市場課題

規制上のハードルと承認プロセス

主要市場動向

生分解性材料とバイオエンジニアリング材料

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の人工血管市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 用途別（大動脈疾患、末梢動脈疾患、血液透析）
    • ポリマー別（ポリジオキサノン、エラストマー、ポリエチレンテレフタレート、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米の人工血管市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の人工血管市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋地域の人工血管市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の人工血管市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの人工血管市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 世界の人工血管市場：SWOT分析

第14章 競合情勢

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16268

The Global Artificial Blood Vessels Market was valued at USD 301.58 million in 2024 and is projected to reach USD 421.51 million by 2030, expanding at a CAGR of 5.74% during the forecast period. This market represents a vital segment of the medical device industry, focusing on the development and application of vascular grafts for treating cardiovascular and vascular conditions. Artificial blood vessels, both synthetic and tissue-engineered, are integral to life-saving procedures such as bypass surgeries, hemodialysis access, and aortic repair, especially when natural vessels are unsuitable or unavailable. The sector has seen notable advancements in material science and graft design, enhancing safety, durability, and surgical outcomes. Additionally, the shift towards minimally invasive procedures has accelerated demand for advanced vascular grafts that reduce recovery times and procedural risks, positioning the market for sustained growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 301.58 Million
Market Size 2030USD 421.51 Million
CAGR 2025-20305.74%
Fastest Growing SegmentAortic Disease
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The escalating incidence of cardiovascular diseases-such as coronary artery and peripheral arterial diseases-serves as a major catalyst for the artificial blood vessels market. This rise is driven by sedentary lifestyles, increased consumption of processed foods, and a surge in obesity and diabetes, all contributing to vascular complications. The global trend of aging populations further exacerbates vulnerability to arterial disorders due to natural physiological changes. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths annually, highlighting the urgent need for advanced vascular solutions. A hereditary predisposition to heart disease and the health impacts of urbanization, including pollution and stress, also heighten the need for effective interventions like artificial grafts, thereby stimulating market growth.

Key Market Challenges

Regulatory Hurdles and Approval Processes

One of the major challenges facing the artificial blood vessels market is navigating the stringent regulatory frameworks required for medical device approval. Compliance with rigorous standards from authorities such as the FDA and EMA involves lengthy and costly clinical evaluations, often delaying product launches. These regulatory procedures can vary significantly across regions, complicating global distribution strategies. Additionally, the focus on patient safety means that any adverse events or safety concerns can trigger intensified scrutiny, potential recalls, and prolonged approval timelines, thereby impeding market entry and expansion.

Key Market Trends

Biodegradable and Bioengineered Materials

A significant trend in the artificial blood vessels market is the adoption of biodegradable and bioengineered materials that emulate the characteristics of natural vessels. These innovations enhance biocompatibility and minimize risks of clotting or immune reactions. Designed to gradually dissolve and integrate with patient tissue, these materials can help reduce long-term complications such as graft failure or calcification. Moreover, their customizable nature allows for tailored solutions that align with individual patient anatomies, improving fit and performance while reducing the risk of rejection, thus paving the way for personalized vascular care.

Key Market Players

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

Report Scope:

In this report, the Global Artificial Blood Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Blood Vessels Market, By Application:

  • Aortic Disease
  • Peripheral Artery Disease
  • Haemodialysis

Artificial Blood Vessels Market, By Polymer:

  • Polydioxanone
  • Elastomer
  • Polyethylene Terephthalate
  • Others

Artificial Blood Vessels Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Blood Vessels Market.

Available Customizations:

Global Artificial Blood Vessels market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Blood Vessels Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Aortic Disease, Peripheral Artery Disease, Haemodialysis)
    • 5.2.2. By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Blood Vessels Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Polymer
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Blood Vessels Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Polymer
    • 6.3.2. Canada Artificial Blood Vessels Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Polymer
    • 6.3.3. Mexico Artificial Blood Vessels Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Polymer

7. Europe Artificial Blood Vessels Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Polymer
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Blood Vessels Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Polymer
    • 7.3.2. United Kingdom Artificial Blood Vessels Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Polymer
    • 7.3.3. Italy Artificial Blood Vessels Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Polymer
    • 7.3.4. France Artificial Blood Vessels Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Polymer
    • 7.3.5. Spain Artificial Blood Vessels Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Polymer

8. Asia-Pacific Artificial Blood Vessels Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Polymer
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Artificial Blood Vessels Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Polymer
    • 8.3.2. India Artificial Blood Vessels Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Polymer
    • 8.3.3. Japan Artificial Blood Vessels Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Polymer
    • 8.3.4. South Korea Artificial Blood Vessels Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Polymer
    • 8.3.5. Australia Artificial Blood Vessels Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Polymer

9. South America Artificial Blood Vessels Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Polymer
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Artificial Blood Vessels Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Polymer
    • 9.3.2. Argentina Artificial Blood Vessels Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Polymer
    • 9.3.3. Colombia Artificial Blood Vessels Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Polymer

10. Middle East and Africa Artificial Blood Vessels Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Polymer
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Artificial Blood Vessels Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Polymer
    • 10.3.2. Saudi Arabia Artificial Blood Vessels Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Polymer
    • 10.3.3. UAE Artificial Blood Vessels Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Polymer

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Artificial Blood Vessels Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. B. Braun Melsungen
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Becton, Dickinson and Company
  • 14.3. Cook Medical Incorporated
  • 14.4. Humacyte Inc.
  • 14.5. Jotec GmbH
  • 14.6. LeMaitre Vascular Inc
  • 14.7. Medtronic Inc
  • 14.8. Techshot Inc
  • 14.9. Terumo Medical Corporation
  • 14.10. W. L. Gore & Associates, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer